Gated chimeric antigen receptor T-cells: the next logical step in reducing toxicity? (2016)
Attributed to:
Immunotherapy of Epithelial Ovarian Cancer using Autologous Gamma Delta T-cells
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.21037/tcr.2016.06.04
Publication URI: http://dx.doi.org/10.21037/tcr.2016.06.04
Type: Journal Article/Review
Parent Publication: Translational Cancer Research
Issue: S1